3rd Next Generation Lipid-Based Nanoparticles Delivery Summit
Evvnt Promotion / evvnt
Archiv
20.08.2024 - 22.08.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:30 AM - 5:00 PM
Kongressthemen
Initially sparked by COVID-19, renewed interest in lipid-based systems for delivery has now evolved. With an escalating clinical demand and the chance to commercialize lipid-based nanoparticles for novel applications and tissue delivery, the spotlight remains on delivery as the key to achieving clinical and commercial success, unlocking new therapeutic horizons.
Initially sparked by COVID-19, renewed interest in lipid-based systems for delivery has now evolved. With an escalating clinical demand and the chance to commercialize lipid-based nanoparticles for novel applications and tissue delivery, the spotlight remains on delivery as the key to achieving clinical and commercial success, unlocking new therapeutic horizons.
Kongressorganizer (PCO)
Hanson Wade Group
Hanson Wade Group
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2315995-3?pid=4832
Speakers: Amey Bandekar, Associate Director, Sanofi, Ching Kim, Tye Director, Head, Nanoparticle, Sanofi, Daniel Tondera, Head, Biology, Pantherna Therapeutics, and more
URL:
Brochure: https://go.evvnt.com/2315995-3?pid=4832
Speakers: Amey Bandekar, Associate Director, Sanofi, Ching Kim, Tye Director, Head, Nanoparticle, Sanofi, Daniel Tondera, Head, Biology, Pantherna Therapeutics, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2315995-2?pid=4832
Frau Stephanie Nketia
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
